Blockade effect of avian-derived anti-VISTA antibodies on immunosuppressive responses

References

• Akita EM, Nakai S. 1993. Production and purification of Fab’ fragments from chicken egg yolk immunoglobulin Y (IgY). J Immunol Methods. 162:155–164. doi:10.1016/0022-1759(93)90380-p.
   PubMed Web of Science ®Google Scholar
• Andris-Widhopf J, Rader C, Steinberger P, Fuller R, Barbas Iii CF. 2000. Methods for the generation of chicken monoclonal antibody fragments by phage display. J Immunol Methods. 242:159–181. doi:10.1016/s0022-1759(00)00221-0.
   PubMed Web of Science ®Google Scholar
• Barbas CF, Kang AS, Lerner RA, Benkovic SJ. 1991. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci U S A. 88:7978–7982. doi:10.1073/pnas.88.18.7978.
   PubMed Web of Science ®Google Scholar
• Blando J, Sharma A, Higa MG, Zhao H, Vence L, Yadav SS, Kim J, Sepulveda AM, Sharp M, Maitra A, Wargo J. 2019. Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer. Proc Natl Acad Sci U S A. 116:1692–1697. doi:10.1073/pnas.1811067116.
   PubMed Web of Science ®Google Scholar
• Cai YC, Guo J, Chen SH, Tian LG, Steinmann P, Chen MX, Li H, Ai L, Chen JX. 2012. Chicken egg yolk antibodies (IgY) for detecting circulating antigens of Schistosoma japonicum. Parasitol Int. 61:385–390. doi:10.1016/j.parint.2012.01.008.
   PubMed Web of Science ®Google Scholar
• Flajnik MF, Tlapakova T, Criscitiello MF, Krylov V, Ohta Y. 2012. Evolution of the B7 family: co-evolution of B7H6 and NKp30, identification of a new B7 family member, B7H7, and of B7's historical relationship with the MHC. Immunogenetics. 64:571–590. doi:10.1007/s00251-012-0616-2.
   PubMed Web of Science ®Google Scholar
• Flies DB, Higuchi T, Chen L. 2015. Mechanistic Assessment of PD-1H Coinhibitory Receptor-Induced T Cell Tolerance to Allogeneic Antigens. J Immunol. 194:5294–5304. doi:10.4049/jimmunol.1402648.
   PubMed Web of Science ®Google Scholar
• Gassmann M, Thömmes P, Weiser T, Hübscher U. 1990. Efficient production of chicken egg yolk antibodies against a conserved mammalian protein. FASEB J. 4:2528–2532. doi:10.1096/fasebj.4.8.1970792.
   PubMed Web of Science ®Google Scholar
• Groves DJ, Morris BA. 2000. Veterinary sources of nonrodent monoclonal antibodies: interspecific and intraspecific hybridomas. Hybridoma. 19:201–214. doi:10.1089/02724570050109602.
   PubMedGoogle Scholar
• Kon E, Benhar I. 2019. Immune checkpoint inhibitor combinations: Current efforts and important aspects for success. Drug Resist Updat. 45:13–29. doi:10.1016/j.drup.2019.07.004.
   PubMed Web of Science ®Google Scholar
• Kuklinski LF, Yan S, Li Z, Fisher JL, Cheng C, Noelle RJ, Angeles CV, Turk MJ, Ernstoff MS. 2018. VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival. Cancer Immunol Immunother. 67:1113–1121. doi:10.1007/s00262-018-2169-1.
   PubMed Web of Science ®Google Scholar
• Le Mercier I, Chen W, Lines JL, Day M, Li J, Sergent P, Noelle RJ, Wang L. 2014. VISTA Regulates the Development of Protective Antitumor Immunity. Cancer Res. 74:1933–1944. doi:10.1158/0008-5472.CAN-13-1506.
   PubMed Web of Science ®Google Scholar
• Lines JL, Pantazi E, Mak J, Sempere LF, Wang L, O'Connell S, Ceeraz S, Suriawinata AA, Yan S, Ernstoff MS, Noelle R. 2014a. VISTA is an immune checkpoint molecule for human T cells. Cancer Res. 74:1924–1932. doi:10.1158/0008-5472.CAN-13-1504.
   PubMed Web of Science ®Google Scholar
• Lines JL, Sempere LF, Broughton T, Wang L, Noelle R. 2014b. VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy. Cancer Immunol Res. 2:510–517. doi:10.1158/2326-6066.CIR-14-0072.
   PubMed Web of Science ®Google Scholar
• Mulati K, Hamanishi J, Matsumura N, Chamoto K, Mise N, Abiko K, Baba T, Yamaguchi K, Horikawa N, Murakami R, Taki M. 2019. VISTA expressed in tumour cells regulates T cell function. Br J Cancer. 120:115–127. doi:10.1038/s41416-018-0313-5.
   PubMed Web of Science ®Google Scholar
• Muller YA, Chen Y, Christinger HW, Li B, Cunningham BC, Lowman HB, de Vos AM. 1998. VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface. Structure. 6:1153–1167. doi:10.1016/s0969-2126(98)00116-6.
   PubMed Web of Science ®Google Scholar
• Rahbarnia L, Farajnia S, Babaei H, Majidi J, Veisi K, Ahmadzadeh V, Akbari B. 2017. Evolution of phage display technology: from discovery to application. J Drug Target. 25:216–224. doi:10.1080/1061186X.2016.1258570.
   PubMed Web of Science ®Google Scholar
• Rahman S, Van Nguyen S, Icatlo Jr FC, Umeda K, Kodama Y. 2013. Oral passive IgY-based immunotherapeutics: a novel solution for prevention and treatment of alimentary tract diseases. Hum Vaccin Immunother. 9:1039–1048. doi:10.4161/hv.23383.
   PubMed Web of Science ®Google Scholar
• Shih HH, Tu C, Cao W, Klein A, Ramsey R, Fennell BJ, Lambert M, Shúilleabháin DN, Autin B, Kouranova E, Laxmanan S. 2012. An ultra-specific avian antibody to phosphorylated tau protein reveals a unique mechanism for phosphoepitope recognition. J Biol Chem. 287:44425–44434. doi:10.1074/jbc.M112.415935.
   PubMed Web of Science ®Google Scholar
• Shim H. 2016. Therapeutic Antibodies by Phage Display. Curr Pharm Des. 22:6538–6559. doi:10.2174/1381612822666160923113714.
   PubMed Web of Science ®Google Scholar
• Tsai KC, Chiang CW, Lo YN, Chang FL, Lin TY, Chang CY, Chen WC, Lee YC. 2018. Generation and characterization of avian-derived anti-human CD19 single chain fragment antibodies. Anim Biotechnol. 1–9. doi:10.1080/10495398.2018.1486323.
   Web of Science ®Google Scholar
• Tsurushita N, Park M, Pakabunto K, Ong K, Avdalovic A, Fu H, Jia A, Vásquez M, Kumar S. 2004. Humanization of a chicken anti-IL-12 monoclonal antibody. J Immunol Methods. 295:9–19. doi:10.1016/j.jim.2004.08.018.
   PubMed Web of Science ®Google Scholar
• Villarroel-Espindola F, Yu X, Datar I, Mani N, Sanmamed M, Velcheti V, Syrigos K, Toki M, Zhao H, Chen L, Herbst RS. 2018. Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer. Clin Cancer Res. 24:1562–1573. doi:10.1158/1078-0432.CCR-17-2542.
   PubMed Web of Science ®Google Scholar
• Wang J, Wu G, Manick B, Hernandez V, Renelt M, Erickson C, Guan J, Singh R, Rollins S, Solorz A, Bi M. 2019. VSIG-3 as a ligand of VISTA inhibits human T-cell function. Immunology. 156:74–85. doi:10.1111/imm.13001.
   PubMed Web of Science ®Google Scholar
• Wang L, Rubinstein R, Lines JL, Wasiuk A, Ahonen C, Guo Y, Lu LF, Gondek D, Wang Y, Fava RA, Fiser A. 2011. VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses. J Exp Med. 208:577–592. doi:10.1084/jem.20100619.
   PubMed Web of Science ®Google Scholar
• Xie X, Xuan C, Li T, Wang L, Teng L, Liu J. 2018. High-Density Infiltration of V-domain Immunoglobulin Suppressor of T-cell Activation Up-regulated Immune Cells in Human Pancreatic Cancer. Pancreas. 47:725–731. doi:10.1097/MPA.0000000000001059.
   PubMed Web of Science ®Google Scholar